ola engkvist (astrazeneca): artificial intelligence in drug design, progress and bottlenecks
Published 4 years ago • 540 plays • Length 19:14Download video MP4
Download video MP3
Similar videos
-
32:17
dr. ola engkvist, ph.d. - astrazeneca - head, molecular ai, discovery sciences, r&d
-
1:01
dr ola engkvist phd, head, molecular #ai - discovery sci, r&d, #astrazeneca - ai in drug discovery
-
2:20
astrazeneca: accelerating drug discovery with machine learning and ai on cambridge-1
-
4:15
how ai is accelerating drug discovery - nature's building blocks | bbc storyworks
-
55:49
introduction to ai in drug discovery
-
28:35
a brief introduction to automated machine learning (automl)
-
16:59
generative ai for molecular design & synthesis
-
0:32
this is the 1st drug designed by generative ai in human clinical trials
-
27:40
ola engqvist (astrazeneca)
-
54:34
(ep.6) informatic innovation powering drug discovery - hannes loffler
-
2:38
machine learning for drug discovery (explained in 2 minutes)
-
22:24
jon paul janet | astrazeneca ab - accelerating drug design with ai & simulation
-
1:00
unlocking the potential of data & ai driven drug discovery and development
-
9:41
ai for drug discovery with astrazeneca
-
30:26
ai and automation for drug design
-
14:42
episode 5: ai transformation of drug discovery and development
-
1:36
machine learning and ai across discovery sciences
-
0:27
artificial intelligence and machine learning in drug discovery and development
-
3:31
revolutionising drug discovery with ai
-
1:03
meet cloud analogy at gitex global 2024: your ai & cloud partner